Small hypervascular hepatocellular carcinomas: Value of diffusion-weighted imaging compared with "washout" appearance on dynamic MRI

British Journal of Radiology

Volumn 85, Issue 1018, 2012, Pages

  Kim, D J ^a,b   Yu, Jeong Sik ^a   Kim, J H ^a   Chung, J J ^a   Kim, K W ^a  

^a Yonsei University College of Medicine   (South Korea)

^b CHA University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SIZE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; HEMANGIOMA; HUMAN; HYPERVASCULAR HEPATOCELLULAR CARCINOMA; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DIFFUSION MAGNETIC RESONANCE IMAGING; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84866860411     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/23975164     Document Type: Article

References (35)

1. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001;35:421-30. (Pubitemid 32844200)
2. Bruix J, Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36.
3. Yu JS, Lee JH, Chung JJ, Kim JH, Kim KW. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging. Acta Radiol 2008;49:735-43.
4. Nasu K, Kuroki Y, Nawano S, Kuroki S, Tsukamoto T, Yamamoto S, et al. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 2006;239:122-30.
5. 2-weighted imaging. Radiology 2008;246:812-21.
6. 2-weighted sequence for detection of liver lesions. Invest Radiol 2008;43:261-6.
7. Xu PJ, Yan FH, Wang JH, Lin J, Ji Y. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. J Magn Reson Imaging 2009;29:341-9.
8. Yu JS, Chung JJ, Kim JH, Cho ES, Kim DJ, Ahn JH, et al. Detection of small intrahepatic metastases of hepatocellular carcinomas using diffusion-weighted imaging: comparison with conventional dynamic MRI. Magn Reson Imaging 2011;29:985-92.
9. Piana G, Trinquart L, Meskine N, Barrau V, Beers BV, Vilgrain V. New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases. J Hepatol 2011;55:126-32.
10. Nishie A, Tajima T, Ishigami K, Ushijima Y, Okamoto D, Hirakawa M, et al. Detection of hepatocellular carcinoma (HCC) using super paramagnetic iron oxide (SPIO)-enhanced MRI: added value of diffusion-weighted imaging (DWI). J Magn Reson Imaging 2010;31:373-82.
11. Kim JE, Kim SH, Lee SJ, Rhim H. Hypervascular hepatocellular carcinoma 1 cmor smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging. AJR Am J Roentgenol 2011;196:758-65.
12. 2- weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 1994;192:401-6.
13. Yu JS, Kim KW, Jeong MG, Lee JT, Yoo HS. Nontumorous hepatic arterial-portal venous shunts: MR imaging findings. Radiology 2000;217:750-6.
14. Earls JP, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC. Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Radiology 1997;202:268-73. (Pubitemid 27024138)
15. Lim JH, Choi D, Park CK, Lee WJ, Lim HK. Encapsulated hepatocellular carcinoma: CT-pathologic correlations. Eur Radiol 2006;16:2326-33. (Pubitemid 44349881)
16. Farmer DG, Rosove MH, Shaked A, Busuttil RW. Current treatment modalities for hepatocellular carcinoma. Ann Surg 1994;219:236-47. (Pubitemid 24085118)
17. Digumarthy SR, Sahani DV, Saini S. MRI in detection of hepatocellular carcinoma (HCC). Cancer Imaging 2005;5:20-4.
18. Semelka RC, Martin DR, Balci C, Lance T. Focal hepatic lesions: comparison of dual phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 2001;13:397-401. (Pubitemid 32173407)
19. Sugahara T, Korogi Y, Kochi M, Ikushima I, Shigematu Y, Hirai T, et al. Usefulness of diffusion-weighted MRI with echoplanar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999;9:53-60. (Pubitemid 29068231)
20. 2 shine-through phenomena on diffusion-weighted MR images. Radiology 1999;212:333-9.
21. Naganawa S, Sato C, Nakamura T, Kumada H, Ishigaki T, Miura S, et al. Diffusion-weighted images of the liver: comparison of tumor detection before and after contrast enhancement with superparamagnetic iron oxide. J Magn Reson Imaging 2005;21:836-40. (Pubitemid 40770878)
22. Koike N, Cho A, Nasu K, Seto K, Nagaya S, Ohshima Y, et al. Role of diffusion-weighted magnetic resonance imaging in the differential diagnosis of focal hepatic lesions. World J Gastroenterol 2009;15:5805-12.
23. Kim T, Murakami T, Takahashi S, Hori M, Tsuda K, Nakamura H. Diffusion-weighted single-shot echoplanar MRimaging for liver disease. AJR Am J Roentgenol 1999;173:393-8. (Pubitemid 29347365)
24. Taouli B, Tolia AJ, Losada M, Babb JS, Chan ES, Bannan MA, et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol 2007;189:799-806. (Pubitemid 47479760)
25. Kwee TC, Takahara T, Ochiai R, Nievelstein RA, Luijten PR. Diffusion-weighted wholebody imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 2008;18:1937-52.
26. Taouli B, Sandberg A, Stemmer A, Parikh T, Wong S, Xu J, et al. Diffusion-weighted imaging of the liver: comparison of navigator triggered and breathhold acquisitions. J Magn Reson Imaging 2009;30:561-8.
27. 2-weighted MR imaging to gadolinium-enhanced three-dimensional dynamic MR imaging for the detection of small hepatocellular carcinomas. Eur J Radiol 2008;67:304-10.
28. van den Bos IC, Hussain SM, Dwarkasing RS, Hop WC, Zondervan PE, de Man RA, et al. MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns. J Magn Reson Imaging 2007;26:1548-55. (Pubitemid 350291283)
29. Shimizu A, Ito K, Koike S, Fujita T, Shimizu K, Matsunaga N. Cirrhosis or chronic hepatitis: evaluation of small (≤ 2-cm) early-enhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging. Radiology 2003;226:550-5. (Pubitemid 36313448)
30. Holland AE, Hecht EM, Hahn WY, Kim DC, Babb JS, Lee VS, et al. Importance of small (≤20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 2005;237:938-44. (Pubitemid 41636384)
31. Kanematsu M, Kondo H, Semelka RC, Matsuo M, Goshima S, Hoshi H, et al. Early-enhancing non-neoplastic lesions on gadolinium-enhanced MRI of the liver. Clin Radiol 2003;58:778-86.
32. Baert AL, Marchal GJ, Wilms GE, Usewils RM, Fever JM. A comparative study angiography and dynamic computed tomography in liver angioma. A report of 15 cases. J Comput Tomogr 1982;6:245-55. (Pubitemid 13153138)
33. Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Muhi A, et al. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging. Radiology 2010;256:151-8.
34. Golfieri R, Renzulli M, Lucidi V, Corcioni B, Trevisani F, Bolondi L. Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to dynamic MRI in the detection of hypovascular small (≤2 cm) HCC in cirrhosis. Eur Radiol 2011;21:1233-42.
35. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-2.